BlackRock Health Sciences Opportunities Portfolio

4 / 5 Stars
3 4 5 1 1
Zacks Investment Research
4 (Sell)
Standard & Poor's
4 / 5 Stars
A (Buy)

U.S. News evaluated 33 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all BlackRock funds

See full Health rankings

See more fund rankings


The fund has returned 34.03 percent over the past year, 21.59 percent over the past three years, 21.24 percent over the past five years, and 14.04 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 11.0%
1 Year 34.0%
3 Years (Annualized) 21.6%
5 Years (Annualized) 21.2%
10 Years (Annualized) 14.0%

See more SHSSX performance


The investment seeks to provide long-term growth of capital. The fund invests at least 80% of total assets in equity securities, primarily common stock, of companies in health science and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It concentrates its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.


Fees are Low compared to funds in the same category.
BlackRock Health Sciences Opportunities Portfolio has an expense ratio of 0.94 percent.

See more SHSSX fees


Risk is Below Average compared to funds in the same category according to Morningstar.

See more SHSSX risk